YOU WONT BELIEVE: 15 - What They Never Told You

Groundbreaking twice-a-year HIV drug that could stop transmission approved

It's unclear how many people in the US and abroad will get access to the powerful new HIV prevention medication

The Independent UK · Jun 19, 2025

US Approves Gilead's Twice-yearly Injection To Prevent HIV

The US Food and Drug Administration on Wednesday approved Gilead Sciences' twice-yearly injection to prevent HIV -- a move the company hailed as a major breakthrough in the fight against the sexually transmitted virus.

International Business Times · Jun 18, 2025

Here’s what to know about the twice-yearly preventative HIV shot

A twice-yearly drug called lenacapavir is now the longest-lasting type of PrEP

The Independent UK · Jun 18, 2025

Gay and bisexual men will soon be able to donate blood and plasma

Many gay and bisexual men have been excluded from donating blood and plasma (the liquid portion of blood) for decades because of rules developed during the HIV crisis in the 1980s.

The Conversation · Jun 18, 2025

Ban on gay and bisexual men donating blood and plasma in Australia to be scrapped

Lifeblood heralds ‘world-leading plasma pathway’ amid change to HIV-era restrictions

The Guardian - AU · Jun 18, 2025

When developing countries band together, lifesaving drugs become cheaper and easier to buy − with trade-offs

Procuring lifesaving drugs is a daunting challenge in many low- and middle-income countries. Essential treatments are often neither available nor affordable in these nations, even decades after the drugs entered the market.

The Conversation · Jun 17, 2025

Congress should be ashamed over helping Trump cut foreign aid, activists say

Campaigners say the US government has been withholding funds for orphans and vulnerable children unlawfully – before a vote in Congress has backed Trump’s move

The Independent UK · Jun 17, 2025

‘HIV-ending’ drug could be made for just $25 per patient a year, say researchers

As regulator prepares to approve Lenacapavir in the US, campaigners are urging the manufacturer, Gilead, to make it ‘available and affordable for all who need it’

The Guardian - UK · Jun 17, 2025

South Africa is at the heart of the HIV pandemic. What happens now the money has been cut?

With 12% of the population living with the virus, Trump’s sudden withdrawal of funding stands to undo decades of progress

The Guardian - UK · Jun 17, 2025

‘People weep in its presence’: how the UK Aids Memorial Quilt became one of our great works of art

It began as a simple act of remembrance, dedicated to those who lost their lives to Aids. Now this ever-growing patchwork of grave-plot-sized panels has taken on new meaning as one of the most significant artworks of the past 40 years

The Guardian - UK · Jun 16, 2025